Owner Glaxo Group Limited

Inventors Kirby, Ian; Taylor, Alexander H.; Webb, Thomas Matthew; Xue, Yu

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011209713

PCT Pub. Number WO2011/094259

Priority 61/299,010 28.01.10 US

Filing date 26 January 2011

Wipo publication date 4 August 2011

C07K 16/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/06 Drugs for immunological or allergic disorders

C07H 21/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12P 21/08 Preparation of peptides or proteins - Monoclonal antibodies